SCHEMBL6060960

SCHEMBL6060960

CCOP(=O)(OCC)C(Cc1cc(OC)c(O)c(OC)c1)c1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.43
CYP51A1 Q16850 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ERN1 O75460 2/20 0.38
MAPK1 P28482 2/20 0.38
HMGCR P04035 1/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.37
GAA P10253 1/20 0.37
ALOX15 P16050 1/20 0.37
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6061529 0.94 PDE4D (0.40) PDE4DCYP51A1L3MBTL1ERN1MAPK1
SCHEMBL5662741 0.89 FDPS (0.42) PDE4DL3MBTL1ERN1RECQLGAA
SCHEMBL6323025 0.85 L3MBTL1 (0.39) L3MBTL1HMGCRPOLBGAA
SCHEMBL5663721 0.83 FDPS (0.39) PDE4DL3MBTL1ERN1RECQLGAA
SCHEMBL6060881 0.83 GAA (0.43) PDE4DMAPK1POLBRECQLGAA
SCHEMBL6061237 0.81 KCNA5 (0.44) ALDH1A1SLC6A2SLC6A4NPC1LMNA
SCHEMBL5665099 0.79 FDPS (0.45) PDE4DL3MBTL1ERN1RECQLGAA
SCHEMBL6305873 0.78 LMNA (0.41) PDE4DL3MBTL1POLBGAANPC1
SCHEMBL5663447 0.78 FDPS (0.44) MAPK1HMGCRPOLBALDH1A1NPC1
SCHEMBL6060950 0.77 POLB (0.37) PDE4DL3MBTL1HMGCRPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482953-A4 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS INC (US) 2006-12-13 EP claimed
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives PHAN HIEU T (CH) 2005-06-09 US claimed
EP-1482953-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES Ilex Products, Inc. (US) 2004-12-08 EP claimed
WO-2003068240-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS, INC. (US) 2003-08-21 WO claimed
EP-1482953-A4 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS INC (US) 2006-12-13 EP disclosed
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives PHAN HIEU T (CH) 2005-06-09 US disclosed
EP-1482953-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES Ilex Products, Inc. (US) 2004-12-08 EP disclosed
WO-2003068240-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS, INC. (US) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives APOB, APOL1, LDLR PDE4D 1369/4885CYP51A1 448/4885L3MBTL1 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.